Baillie Gifford Health Innovation Equities Fund OCSE:GMAB Holdings History
Baillie Gifford Health Innovation Equities Fund's Genmab AS Holding Summary
As of 2024-09-30, Baillie Gifford Health Innovation Equities Fund held 1,255.00 shares of Genmab AS(OCSE:GMAB), totaling kr304,250.00. This investment constitutes 4.46% of their stock portfolio, and Baillie Gifford Health Innovation Equities Fund now holds 0% of the outstanding Genmab AS(OCSE:GMAB) stock.
The initial trade took place in 2022Q1. And since then Baillie Gifford Health Innovation Equities Fund has made 5 purchases of OCSE:GMAB, at an average price of kr2,740.22, for a total of 4,229.00 shares. In addition, there have been 3 sales at an average price of kr1,947.34 for 2,974.00 shares. Based on historical transaction data and OCSE:GMAB's current price of kr1378.00, Baillie Gifford Health Innovation Equities Fund's estimated gain on his OCSE:GMAB holdings is kr-4.07 Mil, reflecting a -35.10% gain to date.
Baillie Gifford Health Innovation Equities Fund OCSE:GMAB (kr1378.00) Holding Chart
Baillie Gifford Health Innovation Equities Fund OCSE:GMAB (kr1378.00) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price kr-/Share | ||
| Shares Sold | 0 | Average Price kr-/Share | ||
| Current Price kr0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
